Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Un nuevo estudio ofrece una explicación de cómo la exposición constante a la luz solar puede aumentar el riesgo de desarrollar cataratas, una opacidad del cristalino que suele ocurrir con la edad.
A new study offers an explanation for how years of chronic sunlight exposure can increase the risk of cataract, a clouding of the eye lens that typically occurs with aging.
Frederick L. Ferris III, M.D., and Emily Y. Chew, M.D., who are director and deputy director of the NEI Division of Epidemiology and Clinical Applications, have received the Helen Keller Prize for Vision Research.
An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of Health.
Dr. Brian Brooks of NEI has been elected into one of the nation’s most respected medical honor societies, the American Society for Clinical Investigation (ASCI).
Researchers have made progress toward an approach that would use light-sensitive drugs to stimulate cells in the retina and restore vision to people who are blind or visually impaired.